Sanofi: all 2,424 studies
Page 9 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple SclerosisCompletedNCT00050778Phase 2Results posted
- Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast CancerCompletedNCT00021255Phase 3Results posted
- A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events (OPTIMUS RISK - Italy)CompletedNCT07906132
- A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events (OPTIMUS RISK - Spain)Active, not recruitingNCT07905534
- A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events (OPTIMUS RISK - Netherlands)CompletedNCT07905508
- Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19Active, not recruitingNCT07861542Phase 4
- An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 InhibitionActive, not recruitingNCT07855250Phase 1
- Impact of Alirocumab on Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease But Without Prior Ischemic EventsCompletedNCT07734753
- Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsCompletedNCT07646548Phase 1
- An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the CzechiaCompletedNCT07634692
- RSV Immunisation Status in Queensland (Australia)CompletedNCT07615192
- Alirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD)CompletedNCT07615179
- Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine Clinical PracticeCompletedNCT07615166
- A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis BronchiectasisSuspendedNCT07547436Phase 2
- A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 YearsActive, not recruitingNCT07536048
- Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of AgeActive, not recruitingNCT07516418Phase 1
- A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japanese Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal PolypsWithdrawnNCT07484230Phase 3
- An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal PolypsActive, not recruitingNCT07424144Phase 3
- A Study of Elenestinib in Healthy Adult Female ParticipantsCompletedNCT07388511Phase 1
- A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous UrticariaTerminatedNCT07316114
- Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older AdultsActive, not recruitingNCT07295028Phase 1
- A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.CompletedNCT07272629Phase 1
- A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)TerminatedNCT07222189Phase 2
- Phase 3 Single Arm, Open Study on vYF in AdultsCompletedNCT07222059Phase 3
- Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in JapanActive, not recruitingNCT07216079Phase 3
- Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of AgeActive, not recruitingNCT07207408Phase 2
- A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical RemissionActive, not recruitingNCT07156175Phase 2
- A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult ParticipantsCompletedNCT07146750Phase 1
- Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in ChinaCompletedNCT07135986Phase 3
- Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in IndiaActive, not recruitingNCT07109297Phase 4
- A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric PopulationActive, not recruitingNCT07103148Phase 3
- Validation of Chlamydia Diagnostic Codes in TriNetX US EHR DataCompletedNCT07094373
- Safety and Immunogenicity of NVX-CoV2705CompletedNCT07079670Phase 3
- Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of AgeCompletedNCT07071558Phase 1
- Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in AdultsCompletedNCT07002060Phase 3
- Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in GermanyCompletedNCT07002047
- Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgeActive, not recruitingNCT06975878Phase 3
- A Study to Investigate the Efficacy and Safety of Brivekimig in Adult Participants With Ulcerative ColitisActive, not recruitingNCT06975722Phase 2
- Study of BLU-808 in Healthy Adult ParticipantsCompletedNCT06948032Phase 1
- Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)Active, not recruitingNCT06931405Phase 2
- Study of BLU-808 in Allergic RhinoconjunctivitisCompletedNCT06922448Phase 2
- Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical StudyActive, not recruitingNCT06914908Phase 2
- Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and OlderActive, not recruitingNCT06907511Phase 1/2
- Description of Patients With Type 1 Diabetes Treated With TeplizumabCompletedNCT06892002
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisTerminatedNCT06867094Phase 2
- A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.CompletedNCT06850051Phase 1
- Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and AdolescentsActive, not recruitingNCT06838000Phase 3
- French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)Active, not recruitingNCT06837454
- A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal PolypsActive, not recruitingNCT06834360Phase 3
- A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal PolypsActive, not recruitingNCT06834347Phase 3
- Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German InfantsCompletedNCT06824207
- Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgeActive, not recruitingNCT06824194Phase 3
- Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgeActive, not recruitingNCT06824181Phase 3
- Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® MoleculeActive, not recruitingNCT06812988Phase 2
- Actual Use Trial of Tadalafil 5 mgCompletedNCT06805513Phase 3
- Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German ParticipantsCompletedNCT06800885
- Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of KoreaCompletedNCT06793826
- Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 DiabetesActive, not recruitingNCT06791291Phase 2
- A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic DermatitisCompletedNCT06790121Phase 2
- A Study to Assess Tolerability of the Trivalent Recombinant Vaccine in Individuals Aged 18 and Older Using the Vaccinees Perception of Injection QuestionnaireCompletedNCT06765187
- A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and OlderCompletedNCT06744205Phase 1/2
- Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgeActive, not recruitingNCT06736041Phase 3
- Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and OlderCompletedNCT06727058Phase 1/2
- A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes MellitusCompletedNCT06716424Phase 4
- A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi ArabiaCompletedNCT06714461
- A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi ArabiaCompletedNCT06714448
- A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the KneeCompletedNCT06704932Phase 1
- Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)CompletedNCT06698198Phase 1
- Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and OlderCompletedNCT06695130Phase 1/2
- Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and OlderCompletedNCT06695117Phase 1/2
- A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal PolypsCompletedNCT06691113Phase 2
- A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)CompletedNCT06687980Phase 3
- A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)CompletedNCT06687967Phase 3
- Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and OlderActive, not recruitingNCT06686654Phase 1/2
- An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 SubstratesCompletedNCT06686628Phase 1
- A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in TaiwanActive, not recruitingNCT06684314
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaActive, not recruitingNCT06676319Phase 2
- Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)CompletedNCT06665308
- A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular DegenerationActive, not recruitingNCT06660667Phase 1/2
- Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and InfantsActive, not recruitingNCT06647407Phase 1/2
- Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of AgeCompletedNCT06641180Phase 3
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.TerminatedNCT06637631Phase 2
- A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic TherapiesCompletedNCT06616415Phase 4
- Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and OlderCompletedNCT06604767Phase 1
- Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 YearsCompletedNCT06583031Phase 1
- Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of AgeCompletedNCT06582056Not applicable
- Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and OverActive, not recruitingNCT06569823Phase 1/2
- A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac DiseaseActive, not recruitingNCT06557772Phase 2
- A Study of RSV-HMPV Bivalent Vaccine VXB-241 in Older AdultsActive, not recruitingNCT06556147Phase 1
- Goal Attainment and Physical Activity in People With Hemophilia ATerminatedNCT06530030
- Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and OlderCompletedNCT06507553Phase 1
- A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal PolypsCompletedNCT06454240Phase 2
- A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia AreataTerminatedNCT06444451Phase 2
- A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)CompletedNCT06444204Phase 1
- Pharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian SubjectsCompletedNCT06444191Phase 1
- A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male ParticipantsCompletedNCT06421714Phase 1
- A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult ParticipantsCompletedNCT06418620Phase 1
- A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult ParticipantsCompletedNCT06418607Phase 1
- Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in SpainActive, not recruitingNCT06415175
- A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisActive, not recruitingNCT06407934Phase 3